Póka R - Search Results

1

Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.

Keserű JS, Soltész B, Lukács J, Márton É, Szilágyi-Bónizs M, Penyige A, Póka R, Nagy B. Keserű JS, et al. Among authors: poka r. J Biotechnol. 2019 Jun 10;298:76-81. doi: 10.1016/j.jbiotec.2019.04.015. Epub 2019 Apr 16. J Biotechnol. 2019. PMID: 31002856

2

[The importance of "free" nucleic acids in the non-invasive diagnostics].

Nagy B, Csanádi Z, Póka R. Nagy B, et al. Among authors: poka r. Orv Hetil. 2016 Nov;157(48):1900-1909. doi: 10.1556/650.2016.30621. Orv Hetil. 2016. PMID: 27889980 Review. Hungarian.

3

Intention-to-Treat Analysis of Radical Trachelectomy for Early-Stage Cervical Cancer With Special Reference to Oncologic Failures: Single-Institutional Experience in Hungary.

Póka R, Molnár S, Daragó P, Lukács J, Lampé R, Krasznai Z, Hernádi Z. Póka R, et al. Int J Gynecol Cancer. 2017 Sep;27(7):1438-1445. doi: 10.1097/IGC.0000000000001048. Int J Gynecol Cancer. 2017. PMID: 28604460

4

Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.

Nagy B, Tóth L, Molnár P, Méhes G, Thurzó L, Póka R, Hernádi Z. Nagy B, et al. Among authors: poka r. Pathol Res Pract. 2017 Aug;213(8):915-921. doi: 10.1016/j.prp.2017.05.011. Epub 2017 Jun 10. Pathol Res Pract. 2017. PMID: 28651933

5

Identification of miR-146a and miR-196a-2 single nucleotide polymorphisms at patients with high-grade serous ovarian cancer.

Lukács J, Soltész B, Penyige A, Nagy B, Póka R. Lukács J, et al. Among authors: poka r. J Biotechnol. 2019 May 20;297:54-57. doi: 10.1016/j.jbiotec.2019.03.016. Epub 2019 Mar 20. J Biotechnol. 2019. PMID: 30904593

6

Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer.

Márton É, Lukács J, Penyige A, Janka E, Hegedüs L, Soltész B, Méhes G, Póka R, Nagy B, Szilágyi M. Márton É, et al. Among authors: poka r. J Biotechnol. 2019 May 20;297:58-65. doi: 10.1016/j.jbiotec.2019.04.003. Epub 2019 Apr 3. J Biotechnol. 2019. PMID: 30953675

7

Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.

Soltész B, Lukács J, Szilágyi E, Márton É, Szilágyi Bónizs M, Penyige A, Póka R, Nagy B. Soltész B, et al. Among authors: poka r. J Biotechnol. 2019 Jun 10;298:16-20. doi: 10.1016/j.jbiotec.2019.03.018. Epub 2019 Apr 5. J Biotechnol. 2019. PMID: 30959137

8

Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.

Orosz L, Orosz G, Veress L, Dosa D, Orosz L Sr, Arany I, Fabian A, Medve L, Pap K, Karanyi Z, Toth Z, Poka R, Than NG, Torok O. Orosz L, et al. Among authors: poka r. J Biotechnol. 2019 Jul 20;300:11-19. doi: 10.1016/j.jbiotec.2019.04.017. Epub 2019 May 2. J Biotechnol. 2019. PMID: 31055145

9

Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples.

Dvorská D, Braný D, Nagy B, Grendár M, Poka R, Soltész B, Jagelková M, Zelinová K, Lasabová Z, Zubor P, Danková Z. Dvorská D, et al. Among authors: poka r. Int J Mol Sci. 2019 Aug 23;20(17):4119. doi: 10.3390/ijms20174119. Int J Mol Sci. 2019. PMID: 31450846 Free PMC article.

10

Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients.

Penyige A, Márton É, Soltész B, Szilágyi-Bónizs M, Póka R, Lukács J, Széles L, Nagy B. Penyige A, et al. Among authors: poka r. Int J Mol Sci. 2019 Sep 13;20(18):4533. doi: 10.3390/ijms20184533. Int J Mol Sci. 2019. PMID: 31540229 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters